Global Esketamine Market Outlook 2022

SKU ID : QYR-19489481

No. of pages : 107

Publishing Date : 09-Nov-2021

Esketamine is a medication used as a general anesthetic and for treatment-resistant depression.

The global Esketamine market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
This report focuses on Esketamine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Esketamine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Esketamine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Oral Medications
Injection
Nasal Spray

Segment by Application
General Anesthetic
Treatment-resistant Depression

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Merck
Medkoo
Endo International
Janssen Pharmaceutica
PFIZER

Frequently Asked Questions



This market study covers the global and regional market with an in-depth analysis of the overall growth prospects...
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects including drivers, restraints...
market Reports market Reports